PPP1R3F: A Protein Regulator of T Cell Signaling and Cancer Development
PPP1R3F: A Protein Regulator of T Cell Signaling and Cancer Development
PPP1R3F (Protein Kinase C (PKC) Regulatory Subunit 1 and Pyruvate Kinase 3) is a protein that is expressed in various tissues and cells throughout the body. It is a key regulator of cell signaling pathways, including the T cell signaling pathway. PPP1R3F has also been shown to play a role in the development and progression of various diseases, including cancer. As a result, PPP1R3F has become a focus of interest for researchers as a potential drug target or biomarker.
The T cell signaling pathway is a critical pathway that regulates the immune response to infection and disease. T cells are a type of immune cell that play a critical role in protecting the body against infection and cancer. They are able to recognize and respond to specific antigens, and their signaling pathway is critical for ensuring that they are able to efficiently respond to these antigens.
PPP1R3F is a protein that is expressed in various tissues and cells throughout the body. It is a key regulator of the T cell signaling pathway. This means that it plays a critical role in ensuring that T cells are able to efficiently respond to antigens and are able to participate in the immune response.
In addition to its role in T cell signaling, PPP1R3F has also been shown to play a role in the development and progression of various diseases, including cancer. For example, studies have shown that high levels of PPP1R3F are associated with poor prognosis in patients with pancreatic cancer, a type of cancer that is often treated with chemotherapy.
As a result, PPP1R3F has become a focus of interest for researchers as a potential drug target or biomarker. Researchers are studying the effects of drugs on PPP1R3F to see if they can be used to treat or diagnose various diseases, including cancer.
In conclusion, PPP1R3F is a protein that is expressed in various tissues and cells throughout the body. It is a key regulator of the T cell signaling pathway and has been shown to play a role in the development and progression of various diseases, including cancer. As a result, PPP1R3F has become a focus of interest for researchers as a potential drug target or biomarker. Further research is needed to fully understand the effects of drugs on PPP1R3F and to determine its potential as a treatment or diagnostic tool.
Protein Name: Protein Phosphatase 1 Regulatory Subunit 3F
Functions: Glycogen-targeting subunit for protein phosphatase 1 (PP1)
More Common Targets
PPP1R3G | PPP1R42 | PPP1R7 | PPP1R8 | PPP1R9A | PPP1R9B | PPP2CA | PPP2CB | PPP2R1A | PPP2R1B | PPP2R2A | PPP2R2B | PPP2R2B-IT1 | PPP2R2C | PPP2R2D | PPP2R3A | PPP2R3B | PPP2R3C | PPP2R5A | PPP2R5B | PPP2R5C | PPP2R5D | PPP2R5E | PPP3CA | PPP3CB | PPP3CB-AS1 | PPP3CC | PPP3R1 | PPP3R2 | PPP4C | PPP4R1 | PPP4R1-AS1 | PPP4R1L | PPP4R2 | PPP4R3A | PPP4R3B | PPP4R3C | PPP4R4 | PPP5C | PPP5D1P | PPP6C | PPP6R1 | PPP6R2 | PPP6R2P1 | PPP6R3 | PPRC1 | PPT1 | PPT2 | PPT2-EGFL8 | PPTC7 | PPWD1 | PPY | PPY2P | PQBP1 | PRAC1 | PRAC2 | PRADC1 | PRAF2 | PRAG1 | PRAM1 | PRAME | PRAMEF1 | PRAMEF10 | PRAMEF11 | PRAMEF12 | PRAMEF14 | PRAMEF15 | PRAMEF16 | PRAMEF17 | PRAMEF18 | PRAMEF19 | PRAMEF2 | PRAMEF20 | PRAMEF22 | PRAMEF27 | PRAMEF29P | PRAMEF3 | PRAMEF36P | PRAMEF4 | PRAMEF5 | PRAMEF6 | PRAMEF7 | PRAMEF8 | PRAMEF9 | PRANCR | PRAP1 | PRB1 | PRB2 | PRB3 | PRB4 | PRC1 | PRC1-AS1 | PRCC | PRCD | PRCP | PRDM1 | PRDM10 | PRDM10-DT | PRDM11 | PRDM12